ROC‐AUC analysis showed that PVT1 may discriminate ALL and healthy samples with adequate sensitivity and specificity, so it can be considered as a novel diagnostic biomarker for ALL. This evidence concerns the gene PVT1 and acute lymphoblastic leukemia.